Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Denmark
Ecuador
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
India
Ireland
Italy
Japan
Korea
Latin America
Mexico
Netherlands
Norway
Peru
Russia
South Africa
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
Venezuela
Lilly
  • Who We Are
    • Governance
      • Board of Directors
      • Executive Committee
    • Business Areas
      • Bio-Medicines
      • Diabetes
      • Oncology
    • Diversity & Inclusion
      • Diversity in Clinical Trials
      • Supplier Diversity
    • Lilly Foundation
    • Grant Office
  • Caring
    • Improving Global Health
      • Patient Programs
    • Strengthening Communities
      • Giving
      • Volunteering
      • Education
    • Operating Responsibly
      • Ethics and Compliance Program
      • Transparency
  • Discovery
    • Clinical Development Pipeline
    • R&D Partnering
    • Clinical Trials
      • Clinical Trials Transparency
      • Expanded Access
    • Research Ethics
  • Products
    • Historic Products
    • HCP Medical Information
    • Patient Safety
      • Patient’s Role
      • Provider’s Role
      • FDA's Role
      • Lilly's Role
    • Anti-Counterfeiting
    • Making Safe, High-Quality Medicine
  • Careers
  • Investors
  • Partners
    • Scientific Areas of Interest
    • Scientific Partnering
  • Newsroom
    • Media Contacts
    • Blogs
    • Press Releases
      • Press Release Archives
  • Media Contacts
  • Blogs
  • Press Releases
  • Q3 2019 Financial Results

    Q3 2019 Financial Results

  • Lilly's Lower-Priced Insulin Now Available

    Lilly's Lower-Priced Insulin Now Available

  • Lilly Diabetes Solution Center Offers Insulin Affordability Assistance

    Lilly Diabetes Solution Center Offers Insulin Affordability Assistance

  • 2018 Integrated Summary Report

    Lilly 2018 Integrated Summary Report

  • LillyPad | December 5, 2019

    Helping People with Rheumatoid Arthritis (RA)

    Today’s guest blog comes from  Anabela Cardoso, M.D., Lilly Immunology Global Brand Development LeaderMany patients, especially those with rheumatoid arthritis (RA), have complicated, individualized t…

  • Press Release | December 5, 2019

    Lilly Announces New Leadership and Strategy in Oncology Research and Development

    New organization to combine speed and agility of Loxo with scale and capabilities of Lilly INDIANAPOLIS , Dec. 5, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new leadership…

  • LillyPad EU | December 3, 2019

    #RAMatters: perspectives of a healthcare professional

    Interview with Professor Dr. Rieke Alten, Head of the Department of Internal Medicine and Rheumatology at Schlosspark-Klinik, University Medicine Berlin.What is the focus of your practice/research?I a…

  • Press Release | December 2, 2019

    Lilly to Participate in Evercore ISI 2nd Annual HealthCONx Conference

    INDIANAPOLIS , Dec. 2, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 2 nd Annual HealthCONx Conference on Wednesday, December 4, 2019 . Daniel Skovronsky…

  • Press Release | December 2, 2019

    Eli Lilly and Company Unveils Shared Innovation Laboratory in South San Francisco

    Lilly Gateway Labs will provide biotech companies direct access to Lilly scientists and expertise INDIANAPOLIS , Dec. 2, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today unveiled its firs…

Lilly
  • Privacy Statement
  • Terms of Use
  • Diversity
  • Suppliers
  • Login
  • Sitemap
  • Contact

Copyright © 2019 Eli Lilly and Company. All rights reserved.